{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:04:06Z","timestamp":1790805846819,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81730008"],"award-info":[{"award-number":["81730008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970137"],"award-info":[{"award-number":["81970137"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970158"],"award-info":[{"award-number":["81970158"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770130"],"award-info":[{"award-number":["81770130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670148"],"award-info":[{"award-number":["81670148"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00277-020-04199-9","type":"journal-article","created":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T10:02:31Z","timestamp":1599300151000},"page":"2639-2648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Incidence, risk factors and outcome of extramedullary relapse after allogeneic hematopoietic stem cell transplantation in patients with adult acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"99","author":[{"given":"Jian","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2723-1621","authenticated-orcid":false,"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,5]]},"reference":[{"issue":"3","key":"4199_CR1","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","volume":"109","author":"AK Fielding","year":"2007","unstructured":"Fielding AK, Richards SM, Chopra R, Lazarus HM, Litzow MR, Buck G, Durrant IJ, Luger SM, Marks DI, Franklin IM, AK MM, Tallman MS, Rowe JM, Goldstone AH, Medical Research Council of the United Kingdom Adult ALLWP, Eastern Cooperative Oncology G (2007) Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12\/ECOG 2993 study. Blood 109(3):944\u2013950. https:\/\/doi.org\/10.1182\/blood-2006-05-018192","journal-title":"Blood"},{"issue":"7","key":"4199_CR2","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.bbmt.2017.03.023","volume":"23","author":"N Shem-Tov","year":"2017","unstructured":"Shem-Tov N, Saraceni F, Danylesko I, Shouval R, Yerushalmi R, Nagler A, Shimoni A (2017) Isolated extramedullary relapse of acute leukemia after allogeneic stem cell transplantation: different kinetics and better prognosis than systemic relapse. Biology of Blood and Marrow Transplantation 23(7):1087\u20131094. https:\/\/doi.org\/10.1016\/j.bbmt.2017.03.023","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"7","key":"4199_CR3","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.bbmt.2014.03.030","volume":"20","author":"L Ge","year":"2014","unstructured":"Ge L, Ye F, Mao X, Chen J, Sun A, Zhu X, Qiu H, Jin Z, Miao M, Fu C, Ma X, Chen F, Xue S, Ruan C, Wu D, Tang X (2014) Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia. Biol Blood Marrow Transplant 20(7):1040\u20131047. https:\/\/doi.org\/10.1016\/j.bbmt.2014.03.030","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"4199_CR4","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1016\/j.humpath.2014.07.022","volume":"45","author":"Q Huang","year":"2014","unstructured":"Huang Q, Reddi D, Chu P, Snyder DS, Weisenburger DD (2014) Clinical and pathologic analysis of extramedullary tumors after hematopoietic stem cell transplantation. Hum Pathol 45(12):2404\u20132410. https:\/\/doi.org\/10.1016\/j.humpath.2014.07.022","journal-title":"Hum Pathol"},{"issue":"4","key":"4199_CR5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41409-018-0303-5","volume":"54","author":"G Gunes","year":"2018","unstructured":"Gunes G, Goker H, Demiroglu H, Malkan UY, Buyukasik Y (2018) Extramedullary relapses of acute leukemias after allogeneic hematopoietic stem cell transplantation: clinical features, cumulative incidence, and risk factors. Bone Marrow Transplant 54(4):595\u2013600. https:\/\/doi.org\/10.1038\/s41409-018-0303-5","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"4199_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.bbmt.2006.09.005","volume":"13","author":"ML Arellano","year":"2007","unstructured":"Arellano ML, Langston A, Winton E, Flowers CR, Waller EK (2007) Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience. Biol Blood Marrow Transplant 13(1):116\u2013123. https:\/\/doi.org\/10.1016\/j.bbmt.2006.09.005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"4199_CR7","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.leukres.2013.08.017","volume":"37","author":"H Shimizu","year":"2013","unstructured":"Shimizu H, Saitoh T, Hatsumi N, Takada S, Handa H, Jimbo T, Sakura T, Miyawaki S, Nojima Y (2013) Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia. Leuk Res 37(11):1477\u20131481. https:\/\/doi.org\/10.1016\/j.leukres.2013.08.017","journal-title":"Leuk Res"},{"issue":"2","key":"4199_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3324\/haematol.2012.073189","volume":"98","author":"AC Harris","year":"2013","unstructured":"Harris AC, Kitko CL, Couriel DR, Braun TM, Choi SW, Magenau J, Mineishi S, Pawarode A, Yanik G, Levine JE (2013) Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes. Haematologica 98(2):179\u2013184. https:\/\/doi.org\/10.3324\/haematol.2012.073189","journal-title":"Haematologica"},{"issue":"7","key":"4199_CR9","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41409-018-0093-9","volume":"53","author":"N Alhashim","year":"2018","unstructured":"Alhashim N, Aljurf M, Hassanein M, Chaudhri N, Hashmi S, El-Gohary G, Alsharif F, Alsermani M, Alhumaid M, Beihany AA, Shaheen M, Hanbali A, Alfraih F, Mohamed S, Alzahrani H, Elhassan T, Eldali A, Rasheed W, Ahmed S, Almohareb F, El Fakih R (2018) Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia: clinical characteristics, incidence, risk factors and outcomes. Bone Marrow Transplant 53(7):838\u2013843. https:\/\/doi.org\/10.1038\/s41409-018-0093-9","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"4199_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00292-002-0572-y","volume":"23","author":"A Schmitt-Graff","year":"2002","unstructured":"Schmitt-Graff A, Wickenhauser C, Kvasnicka HM, Dries V, Thiele J (2002) Extramedullary initial manifestations of acute myeloid leukemia (AML). Pathologe 23(6):397\u2013404. https:\/\/doi.org\/10.1007\/s00292-002-0572-y","journal-title":"Pathologe"},{"issue":"5","key":"4199_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11912-012-0247-7","volume":"14","author":"T Liu-Dumlao","year":"2012","unstructured":"Liu-Dumlao T, Kantarjian H, Thomas DA, O'Brien S, Ravandi F (2012) Philadelphia-positive acute lymphoblastic leukemia: current treatment options. Curr Oncol Rep 14(5):387\u2013394. https:\/\/doi.org\/10.1007\/s11912-012-0247-7","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"4199_CR12","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3324\/haematol.2018.196055","volume":"104","author":"AL Fedullo","year":"2019","unstructured":"Fedullo AL, Messina M, Elia L, Piciocchi A, Gianfelici V, Lauretti A, Soddu S, Puzzolo MC, Minotti C, Ferrara F, Martino B, Chiusolo P, Calafiore V, Paolini S, Vignetti M, Vitale A, Guarini A, Foa R, Chiaretti S (2019) Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia. Haematologica 104(2):312\u2013318. https:\/\/doi.org\/10.3324\/haematol.2018.196055","journal-title":"Haematologica"},{"issue":"7","key":"4199_CR13","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1182\/blood-2002-03-0704","volume":"100","author":"H Dombret","year":"2002","unstructured":"Dombret H, Gabert J, Boiron JM, Rigal-Huguet F, Blaise D, Thomas X, Delannoy A, Buzyn A, Bilhou-Nabera C, Cayuela JM, Fenaux P, Bourhis JH, Fegueux N, Charrin C, Boucheix C, Lheritier V, Esperou H, MacIntyre E, Vernant JP, Fiere D, Groupe d'Etude et de Traitement de la Leucemie Aigue Lymphoblastique de lA (2002) Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial. Blood 100(7):2357\u20132366. https:\/\/doi.org\/10.1182\/blood-2002-03-0704","journal-title":"Blood"},{"issue":"3","key":"4199_CR14","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1016\/S1470-2045(19)30031-2","volume":"20","author":"DT Teachey","year":"2019","unstructured":"Teachey DT, Pui CH (2019) Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia. Lancet Oncol 20(3):e142\u2013e154. https:\/\/doi.org\/10.1016\/S1470-2045(19)30031-2","journal-title":"Lancet Oncol"},{"issue":"19","key":"4199_CR15","doi-asserted-by":"publisher","first-page":"e15584","DOI":"10.1097\/MD.0000000000015584","volume":"98","author":"N Xie","year":"2019","unstructured":"Xie N, Zhou J, Zhang Y, Yu F, Song Y (2019) Extramedullary relapse of leukemia after allogeneic hematopoietic stem cell transplantation: a retrospective study. Medicine (Baltimore) 98(19):e15584. https:\/\/doi.org\/10.1097\/MD.0000000000015584","journal-title":"Medicine (Baltimore)"},{"issue":"20","key":"4199_CR16","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391\u20132405. https:\/\/doi.org\/10.1182\/blood-2016-03-643544","journal-title":"Blood"},{"issue":"1","key":"4199_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1053\/j.seminhematol.2008.09.003","volume":"46","author":"N G\u00f6kbuget","year":"2009","unstructured":"G\u00f6kbuget N, Hoelzer D (2009) Treatment of adult acute lymphoblastic leukemia. Semin Hematol 46(1):64\u201375. https:\/\/doi.org\/10.1053\/j.seminhematol.2008.09.003","journal-title":"Semin Hematol"},{"issue":"5","key":"4199_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/sj.bmt.1705889","volume":"41","author":"V Bachanova","year":"2008","unstructured":"Bachanova V, Weisdorf D (2008) Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review. Bone Marrow Transplant 41(5):455\u2013464. https:\/\/doi.org\/10.1038\/sj.bmt.1705889","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"4199_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.bbmt.2011.06.014","volume":"18","author":"W Cao","year":"2012","unstructured":"Cao W, Xiao H, Lai X, Luo Y, Shi J, Tan Y, Zheng W, He J, Xie W, Li L, Ye X, Yu X, Lin M, Cai Z, Huang H (2012) Genetic variations in the mycophenolate mofetil target enzyme are associated with acute GVHD risk after related and unrelated hematopoietic cell transplantation. Biol Blood Marrow Transplant 18(2):273\u2013279. https:\/\/doi.org\/10.1016\/j.bbmt.2011.06.014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"4199_CR20","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED (1995) Consensus conference on acute GVHD grading. Bone Marrow Transplant 15(6):825\u2013828","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"4199_CR21","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.leukres.2013.06.016","volume":"37","author":"X Zhu","year":"2013","unstructured":"Zhu X, Lai X, Luo Y, Shi J, Tan Y, Zheng W, He J, Xie W, Li L, Zhang J, Ye X, Lin M, Cai Z, Huang H (2013) Combination of low-dose mycophenolate mofetil with cyclosporine and methotrexate as GVHD prophylaxis in unrelated donor allogeneic stem cell transplantation. Leuk Res 37(9):1046\u20131051. https:\/\/doi.org\/10.1016\/j.leukres.2013.06.016","journal-title":"Leuk Res"},{"issue":"17","key":"4199_CR22","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1182\/blood-2014-04-571570","volume":"124","author":"Y Luo","year":"2014","unstructured":"Luo Y, Xiao H, Lai X, Shi J, Tan Y, He J, Xie W, Zheng W, Zhu Y, Ye X, Yu X, Cai Z, Lin M, Huang H (2014) T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT. Blood 124(17):2735\u20132743. https:\/\/doi.org\/10.1182\/blood-2014-04-571570","journal-title":"Blood"},{"issue":"12","key":"4199_CR23","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.3324\/haematol.2012.066159","volume":"97","author":"H Xiao","year":"2012","unstructured":"Xiao H, Luo Y, Lai X, Fu S, Shi J, Tan Y, He J, Xie W, Zheng W, Wang LM, Zhang L, Liu L, Ye X, Yu X, Cai Z, Lin M, Huang H (2012) Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies. Haematologica 97(12):1804\u20131812. https:\/\/doi.org\/10.3324\/haematol.2012.066159","journal-title":"Haematologica"},{"issue":"4","key":"4199_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/sj.bmt.1705727","volume":"40","author":"L Scrucca","year":"2007","unstructured":"Scrucca L, Santucci A, Aversa F (2007) Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant 40(4):381\u2013387. https:\/\/doi.org\/10.1038\/sj.bmt.1705727","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"4199_CR25","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/ejh.12909","volume":"99","author":"C Bourlon","year":"2017","unstructured":"Bourlon C, Lipton JH, Deotare U, Gupta V, Kim DD, Kuruvilla J, Viswabandya A, Thyagu S, Messner HA, Michelis FV (2017) Extramedullary disease at diagnosis of AML does not influence outcome of patients undergoing allogeneic hematopoietic cell transplant in CR1. Eur J Haematol 99(3):234\u2013239. https:\/\/doi.org\/10.1111\/ejh.12909","journal-title":"Eur J Haematol"},{"issue":"8","key":"4199_CR26","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/sj.bmt.1704223","volume":"32","author":"KH Lee","year":"2003","unstructured":"Lee KH, Lee JH, Choi SJ, Lee JH, Kim S, Seol M, Lee YS, Kim WK, Seo EJ, Park CJ, Chi HS, Lee JS (2003) Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course. Bone Marrow Transplant 32(8):835\u2013842. https:\/\/doi.org\/10.1038\/sj.bmt.1704223","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"4199_CR27","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.bbmt.2013.04.014","volume":"19","author":"LM Poon","year":"2013","unstructured":"Poon LM, Hamdi A, Saliba R, Rondon G, Ledesma C, Kendrick M, Qazilbash M, Hosing C, Jones RB, Popat UR, Nieto Y, Alousi A, Ciurea S, Shpall EJ, Champlin RE, Kebriaei P (2013) Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 19(7):1059\u20131064. https:\/\/doi.org\/10.1016\/j.bbmt.2013.04.014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"13","key":"4199_CR28","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1182\/blood-2008-07-163212","volume":"113","author":"O Ringden","year":"2009","unstructured":"Ringden O, Pavletic SZ, Anasetti C, Barrett AJ, Wang T, Wang D, Antin JH, Di Bartolomeo P, Bolwell BJ, Bredeson C, Cairo MS, Gale RP, Gupta V, Hahn T, Hale GA, Halter J, Jagasia M, Litzow MR, Locatelli F, Marks DI, McCarthy PL, Cowan MJ, Petersdorf EW, Russell JA, Schiller GJ, Schouten H, Spellman S, Verdonck LF, Wingard JR, Horowitz MM, Arora M (2009) The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. Blood 113(13):3110\u20133118. https:\/\/doi.org\/10.1182\/blood-2008-07-163212","journal-title":"Blood"},{"issue":"2","key":"4199_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.beha.2006.09.002","volume":"20","author":"L Hambach","year":"2007","unstructured":"Hambach L, Spierings E, Goulmy E (2007) Risk assessment in haematopoietic stem cell transplantation: minor histocompatibility antigens. Best Pract Res Clin Haematol 20(2):171\u2013187. https:\/\/doi.org\/10.1016\/j.beha.2006.09.002","journal-title":"Best Pract Res Clin Haematol"},{"issue":"13","key":"4199_CR30","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1182\/blood-2007-06-095265","volume":"110","author":"BE Shaw","year":"2007","unstructured":"Shaw BE, Gooley TA, Malkki M, Madrigal JA, Begovich AB, Horowitz MM, Gratwohl A, Ringden O, Marsh SG, Petersdorf EW (2007) The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood 110(13):4560\u20134566. https:\/\/doi.org\/10.1182\/blood-2007-06-095265","journal-title":"Blood"},{"issue":"5","key":"4199_CR31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/bmt.2011.163","volume":"47","author":"S Yoshihara","year":"2012","unstructured":"Yoshihara S, Ikegame K, Kaida K, Taniguchi K, Kato R, Inoue T, Fujioka T, Tamaki H, Okada M, Soma T, Ogawa H (2012) Incidence of extramedullary relapse after haploidentical SCT for advanced AML\/myelodysplastic syndrome. Bone Marrow Transplant 47(5):669\u2013676. https:\/\/doi.org\/10.1038\/bmt.2011.163","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"4199_CR32","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1038\/leu.2012.156","volume":"26","author":"H Shimizu","year":"2012","unstructured":"Shimizu H, Saitoh T, Tanaka M, Mori T, Sakura T, Kawai N, Kanda Y, Nakaseko C, Yano S, Fujita H, Fujisawa S, Miyawaki S, Kanamori H, Okamoto S (2012) Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma. Leukemia 26(12):2469\u20132473. https:\/\/doi.org\/10.1038\/leu.2012.156","journal-title":"Leukemia"},{"issue":"4","key":"4199_CR33","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1182\/bloodadvances.2018027003","volume":"3","author":"M Yeshurun","year":"2019","unstructured":"Yeshurun M, Weisdorf D, Rowe JM, Tallman MS, Zhang MJ, Wang HL, Saber W, de Lima M, Sandmaier BM, Uy G, Kamble RT, Cairo MS, Cooper BW, Cahn JY, Ganguly S, Camitta B, Verdonck LF, Dandoy C, Diaz MA, Savani BN, George B, Liesveld J, McGuirk J, Byrne M, Grunwald MR, Drobyski WR, Pulsipher MA, Abdel-Azim H, Prestidge T, Wieduwilt MJ, Martino R, Norkin M, Beitinjaneh A, Seo S, Nishihori T, Wirk B, Frangoul H, Bashey A, Mori S, Marks DI, Bachanova V (2019) The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia. Blood Adv 3(4):670\u2013680. https:\/\/doi.org\/10.1182\/bloodadvances.2018027003","journal-title":"Blood Adv"},{"issue":"8","key":"4199_CR34","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/bmt.2015.82","volume":"50","author":"SD Goyal","year":"2015","unstructured":"Goyal SD, Zhang MJ, Wang HL, Akpek G, Copelan EA, Freytes C, Gale RP, Hamadani M, Inamoto Y, Kamble RT, Lazarus HM, Marks DI, Nishihori T, Olsson RF, Reshef R, Ritchie DS, Saber W, Savani BN, Seber A, Shea TC, Tallman MS, Wirk B, Bunjes DW, Devine SM, de Lima M, Weisdorf DJ, Uy GL (2015) Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome. Bone Marrow Transplant 50(8):1057\u20131062. https:\/\/doi.org\/10.1038\/bmt.2015.82","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"4199_CR35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbmt.2011.05.023","volume":"18","author":"M Solh","year":"2012","unstructured":"Solh M, DeFor TE, Weisdorf DJ, Kaufman DS (2012) Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse. Biol Blood Marrow Transplant 18(1):106\u2013112. https:\/\/doi.org\/10.1016\/j.bbmt.2011.05.023","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"4199_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/ajco.12058","volume":"9","author":"C Curley","year":"2013","unstructured":"Curley C, Durrant S, Kennedy GA (2013) Is extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation associated with improved survival? Asia Pac J Clin Oncol 9(3):285\u2013289. https:\/\/doi.org\/10.1111\/ajco.12058","journal-title":"Asia Pac J Clin Oncol"},{"issue":"9","key":"4199_CR37","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/sj.bmt.1702659","volume":"26","author":"GBG Chong","year":"2000","unstructured":"Chong GBG, Szer J, Grigg A (2000) Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy. Bone Marrow Transplant 26(9):1011\u20131015. https:\/\/doi.org\/10.1038\/sj.bmt.1702659","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"4199_CR38","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/bmt.2016.4","volume":"51","author":"S Bohl","year":"2016","unstructured":"Bohl S, von Harsdorf S, Mulaw M, Hofmann S, Babiak A, Maier CP, Schnell J, Hutter-Kronke LM, Scholl K, Wais V, Schlenk RF, Bullinger L, Ringhoffer M, Dohner H, Bunjes D, Bommer M, Kuchenbauer F (2016) Strong impact of extramedullary involvement in high-risk AML patients with active disease receiving the FLAMSA conditioning regimen for HSCT. Bone Marrow Transplant 51(7):994\u2013996. https:\/\/doi.org\/10.1038\/bmt.2016.4","journal-title":"Bone Marrow Transplant"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04199-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-020-04199-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04199-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T23:13:11Z","timestamp":1630797191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-020-04199-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,5]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["4199"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-04199-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,5]]},"assertion":[{"value":"12 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not apply.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}